Bsv Pharma Profile
Key Indicators
- Authorised Capital ₹ 815.00 Cr
- Paid Up Capital ₹ 801.50 Cr
- Company Age 2 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 185.80 Cr
About Bsv Pharma
Bsv Pharma Private Limited (BPPL) is a Private Limited Indian Non-Government Company incorporated in India on 23 February 2022 (Two years and 11 months 10 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 815.00 Cr and a paid-up capital of Rs 801.50 Cr.
The company currently has active open charges totaling ₹185.80 Cr.
The Key Managerial Personnel (KMP) at Bsv Pharma Private Limited India are Rahul Bagaria as CFO and Sidhi Jatkar as Company Secretary. Anupama Pai, Shashank Gupta, and Nilesh Kulkarni serve as directors at the Company.
Company Details
-
Location
Thane, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
-
Apps
Corporate Identity Details
-
CIN/LLPIN
U24100MH2022PTC406102
-
Company No.
150164
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Feb 2022
-
Date of AGM
30 Aug 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Bsv Pharma?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rahul Bagaria | CFO | 29-Mar-2023 | Current |
Sidhi Jatkar
|
Company Secretary | 17-Nov-2022 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Shashank Gupta
|
Director | 23-Feb-2022 | Current |
|
Anupama Pai
|
Director | 23-Feb-2022 | Current |
|
Nilesh Kulkarni
|
Director | 09-Dec-2022 | Current |
Financial Performance of Bsv Pharma.
Bsv Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bsv Pharma?
In 2023, Bsv Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹185.80 Cr
₹0
Charges Breakdown by Lending Institutions
- Citi Bank N.A. : 185.00 Cr
- Others : 0.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Mar 2024 | Others | ₹8.00 M | Open |
| 19 Dec 2022 | Citi Bank N.A. | ₹185.00 Cr | Open |
How Many Employees Work at Bsv Pharma?
Bsv Pharma has a workforce of 637 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bsv Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bsv Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
